Clinical predictors of mortality of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: A cohort study

SH Alfaraj, JA Al-Tawfiq, AY Assiri, NA Alzahrani… - Travel medicine and …, 2019 - Elsevier
Background Since the emergence of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
in 2012, the virus had caused a high case fatality rate. The clinical presentation of …

[HTML][HTML] The Saudi Critical Care Society extracorporeal life support chapter guidance on utilization of veno-venous extracorporeal membrane oxygenation in adults …

…, MA Rajab, IS Al Enezi, AY Assiri… - Saudi Medical …, 2021 - ncbi.nlm.nih.gov
Extracorporeal membrane oxygenation (ECMO) is considered as a supportive treatment
that provides circulatory and ventilatory support and can be thought off as a bridge to organ …

[HTML][HTML] New national centralized extracorporeal membrane oxygenation program during a pandemic: Reaping what we sow!

…, AA Al Bshabshe, AY Assiri… - Saudi Critical Care …, 2022 - journals.lww.com
Extracorporeal membrane oxygenation ECMO was widely utilized during the coronavirus
disease COVID-19 pandemic. ECMO provision in Saudi Arabia has shown notable …

Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta …

…, LB Rosen, AY Asiri, AM Assiri… - Influenza and Other …, 2023 - Wiley Online Library
Background Type I interferons (IFNs) are essential antiviral cytokines induced upon respiratory
exposure to coronaviruses. Defects in type I IFN signaling can result in severe disease …

[HTML][HTML] Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a …

YM Arabi, AY Asiri, AM Assiri, HA Aziz Jokhdar… - Trials, 2020 - Springer
The MIRACLE trial (MERS-CoV Infection tReated with A Combination of Lopinavir/ritonavir
and intErferon-β1b) investigates the efficacy of a combination therapy of lopinavir/ritonavir …

[HTML][HTML] Interferon beta-1b and lopinavir–ritonavir for Middle East respiratory syndrome

YM Arabi, AY Asiri, AM Assiri, HH Balkhy… - … England Journal of …, 2020 - Mass Medical Soc
Background Whether combined treatment with recombinant interferon beta-1b and lopinavir–ritonavir
reduces mortality among patients hospitalized with Middle East respiratory …

Assessment of Th1/Th2 cytokines among patients with Middle East respiratory syndrome coronavirus infection

…, M Nassar, MB Alfageeh, A Assiri… - International …, 2020 - academic.oup.com
Middle East respiratory syndrome coronavirus (MERS-CoV) is a member of the beta-coronavirus
genus of zoonotic origin that emerged in the Arabian Peninsula and is associated with …

[HTML][HTML] Efficacy of tocilizumab in patients with severe COVID-19: Survival and clinical outcomes

…, H Albayat, E Batubara, S Ballool, A Al Assiri… - Journal of infection and …, 2021 - Elsevier
Background SARS-CoV-2 is associated with a severe inflammatory response contributing to
respiratory and systemic manifestations, morbidity, and mortality in patients with coronavirus …

[HTML][HTML] Heterogeneity of treatment effect of interferon-β1b and lopinavir–ritonavir in patients with Middle East respiratory syndrome by cytokine levels

YM Arabi, AY Asiri, AM Assiri, ML Abdullah… - Scientific Reports, 2022 - nature.com
Animal and human data indicate variable effects of interferons in treating coronavirus infections
according to inflammatory status and timing of therapy. In this sub-study of the MIRACLE …

[HTML][HTML] Chemokine Levels among Patients with Middle East Respiratory Syndrome Coronavirus Infection

…, M Bakhrebah, M Nassar, M Alfageeh, A Assiri… - Vaccines, 2023 - mdpi.com
Middle East respiratory syndrome coronavirus (MERS-CoV) is associated with significant
morbidity and mortality due to intense pulmonary inflammation. Enhanced chemokine-…